2 years ago
SANA
AnalystsEmily BodnarEmily Bodnar's Stock Forecasts
AnalystsEmily Bodnar
Sectors:
Analyst Ranking
Bottom 2%
#5486 out of 5556 analysts
Average Return
-4.81%
Win Rate
29%107 out of 367
Risk vs Reward
Poor
Good
Emily Bodnar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rapt Therapeutics IncRAPT | +738.60% | $6.87 | $57.57 | 2025-05-22 - 2026-01-20 | Buy |
Rapt Therapeutics IncRAPT | +567.87% | $8.62 | $57.57 | 2025-07-10 - 2026-01-20 | Buy |
Olema Pharmaceuticals IncOLMA | +471.36% | $4.26 | $24.34 | 2025-03-05 - 2026-03-04 | Buy |
Connect Biopharma Holdings LtdCNTB | +427.27% | $0.55 | $2.90 | 2025-03-31 - 2026-03-30 | Buy |
Olema Pharmaceuticals IncOLMA | +391.82% | $6.72 | $33.05 | 2024-12-12 - 2025-12-12 | Buy |
Emily Bodnar Analyst Color
Get additional color on Emily Bodnar's coverage of popular stocks
3 years ago
FEMY
Emily Bodnar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
First Tracks Biotherapeutics IncTRAX | 5 | Buy | $57.00 | +19.00% | Reiterates | 2 months ago |
Tg Therapeutics IncTGTX | 6 | Buy | $78.00 | +30.38% | Reiterates | 2 months ago |
Odyssey Therapeutics IncODTX | 1 | Buy | $44.00 | +128.81% | Initiates Coverage On | 2 months ago |
Hemab Therapeutics Holdings IncCOAG | 4 | Buy | $60.00 | +22.40% | Maintains | 3 months ago |
Olema Pharmaceuticals IncOLMA | 24 | Buy | $36.00 | +391.13% | Maintains | 3 months ago |
Agenus IncAGEN | 22 | Buy | $25.00 | +249.65% | Maintains | 3 months ago |
Nkarta IncNKTX | 14 | Buy | $14.00 | +709.25% | Maintains | 3 months ago |
Purple Biotech LtdPPBT | 15 | Buy | $17.00 | +1,197.71% | Maintains | 3 months ago |
Vtv Therapeutics IncVTVT | 4 | Buy | $42.00 | +99.71% | Maintains | 3 months ago |
Autolus Therapeutics PLCAUTL | 3 | Buy | $10.00 | +681.25% | Reiterates | 3 months ago |
Agios Pharmaceuticals IncAGIO | 8 | Buy | $55.00 | +87.01% | Maintains | 3 months ago |
Novocure LtdNVCR | 24 | Buy | $52.00 | +291.57% | Maintains | 4 months ago |
Arcus Biosciences IncRCUS | 9 | Buy | $45.00 | +146.17% | Maintains | 4 months ago |
Sab Biotherapeutics IncSABS | 5 | Buy | $10.00 | +230.03% | Reiterates | 5 months ago |
Mink Therapeutics IncINKT | 16 | Buy | $35.00 | +238.16% | Reiterates | 6 months ago |
Artiva Biotherapeutics IncARTV | 3 | Buy | $35.00 | +743.37% | Maintains | 6 months ago |
Anaptysbio IncANAB | 15 | Buy | $66.00 | +42.09% | Reiterates | 7 months ago |
Atossa Therapeutics IncATOS | 15 | Buy | $25.00 | +1,079.25% | Maintains | 7 months ago |
Sana Biotechnology IncSANA | 13 | Buy | $7.00 | +195.36% | Maintains | 8 months ago |
Arcellx IncACLX | 15 | Hold | $115.00 | -0.06% | Downgrades | 9 months ago |
Rapt Therapeutics IncRAPT | 4 | Hold | $58.00 | -0.03% | Downgrades | 10 months ago |
Ventyx Biosciences IncVTYX | 17 | Hold | $14.00 | 0.00% | Downgrades | 10 months ago |
Acrivon Therapeutics IncACRV | 12 | Buy | $19.00 | +1,080.12% | Reiterates | a year ago |
Context Therapeutics IncCNTX | 13 | Buy | $5.00 | N/A | Maintains | a year ago |
Senti Biosciences Holdings IncSNTI | 1 | Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Briacell Therapeutics CorpBCTX | 15 | Buy | $40.00 | N/A | Maintains | a year ago |
Femasys IncFEMY | 25 | Buy | $160.00 | N/A | Maintains | a year ago |
Jasper Therapeutics IncJSPR | 10 | Buy | $600.00 | N/A | Maintains | a year ago |
Nextcure IncNXTC | 9 | Buy | $36.00 | N/A | Reiterates | a year ago |
Transcode Therapeutics IncRNAZ | 17 | Buy | $280.00 | N/A | Maintains | 2 years ago |
Connect Biopharma Holdings LtdCNTB | 6 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Io Biotech IncIOBTQ | 13 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Genelux CorpGNLX | 7 | Buy | $30.00 | N/A | Reiterates | 2 years ago |
Imunon IncIMNN | 13 | Buy | $210.00 | N/A | Reiterates | 2 years ago |
Geron CorpGERN | 5 | Hold | N/A | N/A | Reiterates | 2 years ago |
Acelyrin IncSLRN | 13 | Hold | $6.00 | N/A | Maintains | 2 years ago |
Lantern Pharma IncLTRN | 1 | Hold | N/A | N/A | Reiterates | 3 years ago |
Gracell Biotechnologies IncGRCL | 6 | Hold | $10.00 | N/A | Downgrades | 3 years ago |
Dice Therapeutics IncDICE2 | 8 | Hold | $48.00 | N/A | Reiterates | 3 years ago |
Sqz Biotechnologies CoSQZB | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.